Metal-based G-quadruplex binders for cancer theranostics

E Palma, J Carvalho, C Cruz, A Paulo - Pharmaceuticals, 2021 - mdpi.com
The ability of fluorescent small molecules, such as metal complexes, to selectively recognize
G-quadruplex (G4) structures has opened a route to develop new probes for the …

Evaluation of acridine orange derivatives as DNA-targeted radiopharmaceuticals for Auger therapy: influence of the radionuclide and distance to DNA

E Pereira, L Do Quental, E Palma, MC Oliveira… - Scientific reports, 2017 - nature.com
A new family of 99mTc (I)-tricarbonyl complexes and 125I-heteroaromatic compounds
bearing an acridine orange (AO) DNA targeting unit was evaluated for Auger therapy …

Anticancer activity of structurally related ruthenium (II) cyclopentadienyl complexes

L Côrte-Real, F Mendes, J Coimbra, TS Morais… - JBIC Journal of …, 2014 - Springer
A set of structurally related Ru (η 5-C 5 H 5) complexes with bidentate N, N′-
heteroaromatic ligands have been evaluated as prospective metallodrugs, with focus on …

Evaluation of cellular uptake, cytotoxicity and cellular ultrastructural effects of heteroleptic oxidovanadium (IV) complexes of salicylaldimines and polypyridyl ligands

G Scalese, I Correia, J Benítez, S Rostán… - Journal of Inorganic …, 2017 - Elsevier
Searching for prospective vanadium-based drugs for cancer treatment, a new series of
structurally related [V IV O (L− 2H)(NN)] compounds (1–8) was developed. They include a …

Polymer “ruthenium-cyclopentadienyl” conjugates-New emerging anti-cancer drugs

T Moreira, R Francisco, E Comsa… - European Journal of …, 2019 - Elsevier
In this work, we aimed to understand the biological activity and the mechanism of action of
three polymer-'ruthenium-cyclopentadienyl'conjugates (RuPMC) and a low molecular weight …

The key role of coligands in novel ruthenium (II)-cyclopentadienyl bipyridine derivatives: Ranging from non-cytotoxic to highly cytotoxic compounds

L Côrte-Real, MP Robalo, F Marques… - Journal of Inorganic …, 2015 - Elsevier
A new family of eight ruthenium (II)-cyclopentadienyl bipyridine derivatives, bearing
nitrogen, sulfur, phosphorous and carbonyl sigma bonded coligands, has been synthesized …

Cellular uptake mechanisms of an antitumor ruthenium compound: The endosomal/lysosomal system as a target for anticancer metal-based drugs

L Côrte-Real, AP Matos, I Alho… - Microscopy and …, 2013 - academic.oup.com
Previous studies have described promising antitumor activity of an organometallic Ru (II)
complex, η5-Cyclopentadienyl (2, 2′-bipyridyl)(triphenylphosphane) Ruthenium (II) triflate …

Synthesis and Biological Evaluation of Novel 2‐Aryl Benzimidazoles as Chemotherapeutic Agents

GR Morais, E Palma, F Marques, L Gano… - Journal of …, 2017 - Wiley Online Library
Here, we describe the synthesis and preliminary biological evaluation of novel N‐
unsubstituted and N‐methylated 2‐aryl benzimidazole derivatives that contain fluorinated or …

Insight into the cytotoxicity of polynuclear Cu (I) camphor complexes

TA Fernandes, F Mendes, APS Roseiro, I Santos… - Polyhedron, 2015 - Elsevier
Three new polynuclear Cu (I) camphor complexes,[(CuBr) 2 {(pH 2 NC 6 H 4) NC 10 H 14
O}] n (2d),[(CuCl) 4 {mC 6 H 4 (NC 10 H 14 O) 2}] n (5f) and [(CuBr) 4 {pC 6 H 4 (NC 10 H 14 …

Design and biological evaluation of new platinum (II) complexes bearing ligands with DNA-targeting ability

JM Herrera, F Mendes, S Gama, I Santos… - Inorganic …, 2014 - ACS Publications
A novel series of platinum (II) complexes bearing aliphatic amines and ligands with DNA-
targeting properties was synthesized to achieve more potent and selective metallodrugs. We …